It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CERT’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CERT’s TA Score shows that 4 TA indicator(s) are bullish.
CERT (@Services to the Health Industry) experienced а -5.24% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -6.26%. For the same industry, the average monthly price growth was -11.70%, and the average quarterly price growth was +6.83%.
CERT is expected to report earnings on Feb 26, 2026.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| CERT | DARP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 71% |
| MACD ODDS (%) | N/A | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| Advances ODDS (%) | 17 days ago 77% | 17 days ago 90% |
| Declines ODDS (%) | 2 days ago 82% | 13 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SIIAX | 16.14 | N/A | N/A |
| AlphaCentric Real Income A | |||
| DCGVX | 42.69 | N/A | N/A |
| BNY Mellon Dynamic Value Fund C | |||
| PJERX | 15.93 | N/A | N/A |
| PGIM Jennison Global Equity Income R | |||
| DFUEX | 31.52 | -0.21 | -0.66% |
| DFA US Social Core Equity 2 Portfolio | |||
| HDTVX | 18.28 | -0.21 | -1.14% |
| Janus Henderson International Div T | |||
A.I.dvisor tells us that DARP and CERT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DARP and CERT's prices will move in lockstep.
| Ticker / NAME | Correlation To DARP | 1D Price Change % | ||
|---|---|---|---|---|
| DARP | 100% | N/A | ||
| CERT - DARP | 25% Poorly correlated | -0.49% | ||
| HIVE - DARP | 8% Poorly correlated | -2.53% | ||
| MSFT - DARP | 6% Poorly correlated | -2.70% | ||
| ANET - DARP | 5% Poorly correlated | -2.99% | ||
| NVDA - DARP | 5% Poorly correlated | -2.81% | ||
More | ||||